McCormack, James P.; Rangno, Robert; Lange, Bruce; Parmar, Malvinder S.; Kappel, Joanne Elaine; Mann, Jeffrey; Gladstone, David; Hill, Michael
June 2002
CMAJ: Canadian Medical Association Journal;6/25/2002, Vol. 166 Issue 13, p1649
Academic Journal
Presents letters to the editor about medical topics and research. Data from the COX-2 trials; Safe drug prescribing; Tissue plasminogen activator for acute stroke.


Related Articles

  • NOTES AND NEWS.  // British Medical Journal (Clinical Research Edition);1/16/1988, Vol. 296 Issue 6616, p215 

    Focuses on various reports related to medical cases. Number of AIDS victims; Benefits from treatment with tissue plasminogen activator for patients with acute myocardial infarction; Classification of women died caused by physical occupational injuries.

  • Abstrick of the month. Brewer, P.; Vadeboncoeur, A. // CJEM: Canadian Journal of Emergency Medicine;Mar2003, Vol. 5 Issue 2, p133 

    Comments on several humorous aspects of emergency medicine. Rumors that tissue plasminogen is of benefit as a primary intervention for stroke victims; Rarity of acute interventions in neurology; Decrease in divorce rates in the neurologist group.

  • Latest advice from the SMC.  // PharmacoEconomics & Outcomes News;7/7/2012, Issue 657, p11 

    The article reports on the recommendations made by the Scottish Medicines Consortium (SMC) on June 11, 2012 for the use of several drugs, including alteplase, exenatide and dexamethasone.

  • Commons report signals GP prescribing controls. Pedder, Cato // Pulse;4/9/2005, Vol. 65 Issue 14, p4 

    Focuses on the influence of the Commons Health Select Committee in blaming general practitioners for widespread inappropriate prescribing of drugs as cox-2 inhibitors and antidepressants. Control of the influences of the pharmaceutical industry on GP prescribing; Demand of the committee for...

  • No changes to NSAID prescribing practice in the EU and UK.  // Reactions Weekly;8/13/2005, Issue 1064, p2 

    Discusses issues concerning non-steroidal anti-inflammatory drug (NSAID) prescribing practice in Europe as of August 2005. Reason behind the decision of the British Committee on Safety Medicines (CMS) in relation to NSAID prescribing practice in the country; Basis needed for NSAID prescribing...

  • Tissue plasminogen activator versus heparin for locking dialysis catheters: A systematic review. Firwana, Belal M.; Hasan, Rim; Ferwana, Mazen; Varon, Joseph; Stern, Aaron; Gidwani, Umesh // Avicenna Journal of Medicine;2011, Vol. 1 Issue 2, p29 

    Background and Objectives: Hemodialysis catheters are commonly used when renal replacement therapy is initiated. These catheters have significant complications. Among "locking" solutions used in an attempt to decrease these complications is recombinant tissue plasminogen activator (rt-PA). This...

  • More Alzheimer's.  // Nature;2/2/1995, Vol. 373 Issue 6513, p456 

    Discusses the article in the February 1995 issue of `Nature Medicine' periodical on the role of analogues of the amyloid beta-protein forming plaques in Alzheimer's disease on the activity of tissue-type plasminogen activator (TPA).

  • Journal club: Revisiting intrapleural fibrinolysis in empyema. Fester, Andrew // Thorax;Apr2012, Vol. 67 Issue 4, p308 

    The article presents information on the use of tissue plasminogen activator in combination with DNase for the treatment of pleural infection and the process was compared with placebos.

  • Telemedicine for Stroke: An Idea Whose Time Has Come. Leifer, Dana // Neurology Alert;Oct2007, Vol. 26 Issue 2, p11 

    Outcomes for treatment of stroke with intravenous tissue plasminogen activator (tPA) were similar at community hospitals supported by telemedicine consultation with stroke experts compared to academic stroke centers.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics